NEW BRUNSWICK, NJ – On Friday morning, Johnson & Johnson announced manufacturing, research and development, and technology investments of more than $55 billion in the United States over the next four years.
The company says it represents a 25% increase in investment compared to the previous four years and builds upon the Company’s already elevated U.S. investment levels resulting from the passage of the 2017 Tax Cuts & Jobs Act.
“Today’s announcements accelerate our nearly 140-year legacy as an American innovation engine tackling the world’s toughest healthcare challenges,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “Our increased U.S. investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add U.S.-based jobs but manufacture cutting edge medicines to treat patients in America and around the world.”
$55 Billion Investment Supports American Innovation & Manufacturing
The company’s increased investment in the U.S. over the next four years includes three new advanced manufacturing facilities and the expansion of several existing sites across the Company’s Medicine and MedTech businesses that will create high-paying, high-technology jobs, according to a press release.
Significant investments will also be made in extensive R&D infrastructure aimed at developing lifesaving and life-changing treatments in areas such as oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.
Increased technology investments to help make drug discovery and development faster, support workforce training and enhance our business operations.
With its increased investment over the next four years, the Company’s U.S. economic impact will build upon its already estimated more than $100 billion per year, says the release.
The North Carolina investment creates jobs starting immediately in Wilson, North Carolina, where the Company is officially breaking ground on its new, 500,000 square foot, state-of-the-art biologics manufacturing facility.
